| First Posted | New Trial Filing | Phase | Status |
|---|---|---|---|
| 2026-06-09 | NCT07636226 QL1706 Plus Anlotinib as a Later-line Treatment for Patients With Advanced Lung Cancer | Phase 2/3 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07002346 | INVIGORATE: A Study of QL1706 and Bevacizumab in Advanced First-Line Ovarian Clear Cell… | Ovarian Clear Cell Carcinoma | Recruiting |
| Phase 2/3 | |||
| NCT07636226 | QL1706 Plus Anlotinib as a Later-line Treatment for Patients With Advanced Lung Cancer | Small Cell Lung Cancer | Not Yet Recruiting |
| Phase 2 | |||
| NCT06967103 | QL1706 for the Neoadjuvant Treatment of HR+/HER2- Breast Cancer | Breast Cancer | Recruiting |
| NCT06951997 | QL1706 Plus Chidamide, AG as First-line Treatment for Metastatic Pancreatic Cancer | Metastatic Pancreatic Cancer | Recruiting |
| NCT06787183 | SCRT(Short Course Radiotherapy) Combined With CAPOX Plus QL1706 for Rectal Cancer Liver… | Locally Advanced Rectal Cancer With Liver Metastases | Recruiting |
| NCT07256236 | SKB264 Plus QL1706 in Recurrent or Metastatic Cervical Cancer | Cervical Cancer | Recruiting |
| NCT07091305 | A Study of QL1706 Combined With Chemotherapy Induction on Sequential Immunotherapy… | Limited-stage Small Cell Lung Cancer (LS-SCLC) | Recruiting |
| NCT07315035 | QL1706-SOX vs SOX Alone as Neoadjuvant Therapy for Resectable Diffuse-Type Gastric Cancer | Gastric Cancer Stage III | Not Yet Recruiting |
| NCT07413601 | Phase 2 Clinical Study of Iparomlimab and Tuvonralimab (QL1706) in Combination With… | Triple Negative Breast Cancer Metastatic | Not Yet Recruiting |
| NCT07416058 | PHOENIX: QL1706 Plus Chemotherapy and Bevacizumab in AGA-Resistant, PD-L1 ≥50%… | Lung Adenocarcinoma | Not Yet Recruiting |
| NCT07432594 | Neoadjuvant Aitua (PD-1/CTLA-4 Bispecific) Plus Nab-Paclitaxel and Carboplatin for… | High-grade Serous Ovarian Cancer (HGSOC) | Not Yet Recruiting |
| NCT07530549 | A Phase II Single-arm Clinical Study in the Treatment of Locally Advanced Esophageal… | Local Advanced Esophageal Cancer | Not Yet Recruiting |